LobbedezT., MoldovanR., LecameM., Hurault de LignyB., El HagganW., RyckelynckJ-P.Assisted peritoneal dialysis. Experience in a French renal department.Perit Dial Int2006; 26: 671–6.
2.
Canadian Organ Replacement Register.Treatment of end-stage organ failure in Canada: 2002–2003.Ottawa: Canadian Institute for Health Information; 2005.
3.
United States Renal Data System.USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2005.
4.
LittleJ., IrwinA., MarshallT., RaynerH., SmithS.Predicting a patient's choice of dialysis modality: experience in a United Kingdom renal department.Am J Kidney Dis2001; 37: 981–6.
5.
McLaughlinK., MannsB., MortisG., HonsR., TaubK.Why patients with ESRD do not select self-care dialysis as a treatment option.Am J Kidney Dis2003; 41: 380–5.
6.
StackA.G.Determinants of modality selection among incident US dialysis patients: results from a national study.J Am Soc Nephrol2002; 13: 1279–87.
7.
XueJ.L., EversonS.E., ConstantiniE.G., EbbenJ.P., ChenS.C., AgodoaL.Y.Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics.Kidney Int2002; 61: 741–6.
8.
MiskulinD.C., MeyerK.B., AthienitesN.V., MartinA.A., TerrinN., MarshJ.V.Comorbidity and other factors associated with modality selection in incident dialysis patients: The CHOICE study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease.Am J Kidney Dis2002; 39: 324–36.
9.
JagerK.J., KorevaarJ.C., DekkerF.W., KredietR.T., BoeschotenE.W.The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands.Am J Kidney Dis2004; 43: 891–9.
10.
FentonS.S., SchaubelD.E., DesmeulesM., MorrisonH.I., MaoY., CoplestonP.Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates.Am J Kidney Dis1997; 30: 334–42.
11.
HeafJ.G., LokkegaardH., MadsenM.Initial survival advantage of peritoneal dialysis relative to haemodialysis.Nephrol Dial Transplant2002; 17: 112–17.
12.
CollinsA.J., HaoW., XiaH., EbbenJ.P., EversonS.E., ConstantiniE.G.Mortality risks of peritoneal dialysis and hemodialysis.Am J Kidney Dis1999; 34: 1065–74.
13.
BloembergenW.E., PortF.K., MaugerE.A., WolfeR.A.A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol1995; 6: 177–83.
14.
GaneshS.K., Hulbert-ShearonT., PortF.K., EagleK., StackA.G.Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease.J Am Soc Nephrol2003; 14: 415–24.
15.
StackA.G., MolonyD.A., RahmanN.S., DosekunA., MurthyB.Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States.Kidney Int2003; 64: 1071–9.
16.
JaarB.G., CoreshJ., PlantingaL.C., FinkN.E., KlagM.J., LeveyA.S.Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease.Ann Intern Med2005; 143: 174–83.
17.
SerkesK.D., BlaggC.R., NolphK.D., VoneshE.F., ShapiroF.Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study.Perit Dial Int1990; 10: 15–19.
18.
VoneshE.F., MoranJ.Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol1999; 10: 354–65.
19.
VoneshE.F., SnyderJ.J., FoleyR.N., CollinsA.J.The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.Kidney Int2004; 66: 2389–401.
20.
EvansR.W., ManninenD.L., GarrisonL.P.Jr., HartL.G., BlaggC.R., GutmanR.A.The quality of life of patients with end-stage renal disease.N Engl J Med1985; 312: 553–9.
21.
MerkusM.P., JagerK.J., DekkerF.W., BoeschotenE.W., StevensP., KredietR.T.Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The NECOSAD Study Group.Am J Kidney Dis1997; 29: 584–92.
22.
SennfaltK., MagnussonM., CarlssonP.Comparison of hemodialysis and peritoneal dialysis—a cost-utility analysis.Perit Dial Int2002; 22: 39–47.
23.
WasserfallenJ.B., HalabiG., SaudanP., PernegerT., FeldmanH.I., MartinP.Y.Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysis.Nephrol Dial Transplant2004; 19: 1594–9.
24.
WuA.W., FinkN.E., Marsh-ManziJ.V., MeyerK.B., FinkelsteinF.O., ChapmanM.M.Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures.J Am Soc Nephrol2004; 15: 743–53.
25.
HabachG., BloembergenW.E., MaugerE.A., WolfeR.A., PortF.K.Hospitalization among United States dialysis patients: hemodialysis versus peritoneal dialysis.J Am Soc Nephrol1995; 5: 1940–8.
26.
MurphyS.W., FoleyR.N., BarrettB.J., KentG.M., MorganJ., Bar reP.Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada.Kidney Int2000; 57: 2557–63.
27.
FrimatL., DurandP.Y., Loos-AyavC., VillarsE., PanescuV., BriançonS.Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant.Perit Dial Int2006; 26: 231–9.
28.
KorevaarJ.C., FeithG.W., DekkerF.W., Van ManenJ.G., BoeschotenE.W., BossuytP.M.Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial.Kidney Int2003; 64: 2222–8.
29.
De VecchiA.F., DratwaM., WiedemannM.E.Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: costs and reimbursement/funding of ESRD therapies.Nephrol Dial Transplant1999; 14(Suppl 6): 31–41.
30.
Rodriguez-CarmonaA., Perez FontanM., BouzaP., Garcia FalconT., ValdesF.The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemo-dialysis in a Spanish unit.Adv Perit Dial1996; 12: 93–6.
31.
LaupacisA., KeownP., PusN., KruegerH., FergusonB., WongC.A study of the quality of life and cost-utility of renal transplantation.Kidney Int1996; 50: 235–42.
32.
CroxsonB.E., AshtonT.A cost effectiveness analysis of the treatment of end stage renal failure.N Z Med J1990; 103: 171–4.
33.
de WitG.A., RamsteijnP.G., de CharroF.T.Economic evaluation of end stage renal disease treatment.Health Policy1998; 44: 215–32.
34.
GoereeR., ManalichJ., GrootendorstP., BeecroftM.L., ChurchillD.N.Cost analysis of dialysis treatments for end-stage renal disease (ESRD).Clin Invest Med1995; 18: 455–64.
35.
LeeH., MannsB., TaubK., GhaliW.A., DeanS., JohnsonD.Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.Am J Kidney Dis2002; 40: 611–22.
36.
ChengS.M., KingsburyL., EstridgeC., ConlyJ.M.Optimizing physical space design of hemodialysis units to prevent nosocomial infections.Dialysis & Transplantation1999; 28: 557.